DJIA 16,805.41 127.51 0.76%
NASDAQ 4,483.72 30.92 0.69%
S&P 500 1,964.58 13.76 0.71%
market minute promo

2.46 -0.03 (-1.20%)

REAL-TIME: Last trade at

Extended Hours: $2.46 $0.00 (0.00%)
Quote as of (NASDAQ)



company name or ticker

Recent Quotes

IDRA $2.46 -1.20%
1D 1W 3M 6M 1Y 2Y 3Y
Today's Open $2.50
Previous Close $2.49
Daily Range $2.44 - $2.55
52-Week Range $1.55 - $6.87
Market Cap $206.1M
P/E Ratio -6.23
Dividend (Yield) $0.00 (0.0%)
Volume 400,106
Average Daily Volume 708,455
Current FY EPS -$0.45

Sector

Healthcare

Industry

Drugs

Idera Pharmaceuticals, Inc. (IDRA) Description

The Company is engaged in the discovery and development of synthetic DNA and RNA-based compounds for the treatment of cancer, infectious diseases, autoimmune diseases, and asthma/allergies, and for use as vaccine adjuvants. Website: http://www.iderapharma.com/

News & Commentary

Why Idera Pharmaceuticals Inc. Shares Roared Higher

Idera Pharmaceuticals shares pop following the release of the company's first-quarter earnings results.

Time To Plunge Into Stocks?

Idera Pharmaceuticals Expands Pipeline By Initiating Clinical Development Of Proprietary TLR Antagon

Idera Pharmaceuticals Expands Pipeline By Initiating Clinical Development Of Proprietary TLR Antagonist Candidate IMO-9200

4 Stocks Under $10 to Trade for Breakouts

Idera Pharmaceuticals' (IDRA) CEO Sudhir Agrawal on Q2 2014 Results - Earnings Call Transcript

5 Stocks Setting Up to Break Out

Mid-Afternoon Market Update: Markets Trade In Choppy Session As Elizabeth Arden Shares Remain Down

Mid-Afternoon Market Update: Markets Trade In Choppy Session As Elizabeth Arden Shares Remain Down

Earnings Scheduled For May 13, 2014

Insider Buying On The Rise At These 5 Stocks With Earnings Next Week

See More IDRA News...

IDRA's Top Competitors

IDRA $2.46 (-1.20%)
Current stock: IDRA
AMGN $147.26 (0.01%)
Current stock: AMGN
GILD $110.71 (3.29%)
Current stock: GILD
BIIB $321.67 (1.77%)
Current stock: BIIB